CTNM

NASDAQ:CTNM

Contineum Therapeutics

  • Stock

USD

Last Close

11.01

06/11 21:00

Market Cap

541.73M

Beta: -

Volume Today

132.52K

Avg: -

PE Ratio

−20.64

PFCF: −17.65

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
net income
-7.51M
-
-4.82M
35.78%
41.56M
961.61%
-6.25M
115.04%
-7.77M
24.28%
-8.42M
8.34%
-9.01M
7.03%
-10.27M
13.96%
-14.56M
41.86%
depreciation and amortization
81K
-
73K
9.88%
42K
42.47%
43K
2.38%
37K
13.95%
61K
64.86%
60K
1.64%
62K
3.33%
75K
20.97%
deferred income tax
stock based compensation
491K
-
494K
0.61%
489K
1.01%
477K
2.45%
759K
59.12%
768K
1.19%
2.29M
-
2.25M
1.75%
change in working capital
419K
-
-1.01M
342.00%
1.66M
263.81%
1.12M
32.63%
-2.79M
349.33%
275K
109.86%
-209K
176%
-66K
68.42%
2.95M
4,569.70%
accounts receivables
inventory
accounts payables
23K
-
282K
1,126.09%
-313K
210.99%
656K
309.58%
-625K
195.27%
-70K
88.80%
170K
342.86%
663K
290%
378K
42.99%
other working capital
396K
-
-1.30M
427.27%
1.97M
252.31%
345K
-
-379K
209.86%
34K
108.97%
2.57M
7,464.71%
other non cash items
2.56M
-
385K
84.97%
-2.20M
670.39%
236K
110.75%
263K
11.44%
158K
39.92%
749K
374.05%
1.81M
141.79%
-913K
150.41%
net cash provided by operating activities
-4.08M
-
-5.24M
28.62%
40.67M
875.63%
-5.38M
113.22%
-10.70M
99.07%
-8.12M
24.19%
-8.36M
3.01%
-6.17M
26.20%
-10.20M
65.38%
investments in property plant and equipment
-52K
-
-31K
40.38%
-22K
29.03%
-309K
1,304.55%
-147K
52.43%
-119K
19.05%
-82K
31.09%
-166K
102.44%
acquisitions net
purchases of investments
-12.96M
-
-9.22M
28.89%
-58.58M
535.61%
-52.08M
11.10%
-22.00M
57.76%
-30.64M
39.30%
-69.01M
125.23%
-72.41M
4.92%
-54.35M
24.93%
sales maturities of investments
17.88M
-
18.62M
4.17%
14.15M
24.01%
12.60M
10.95%
31.34M
148.65%
39.52M
26.11%
30.23M
23.51%
42.28M
39.88%
45.13M
6.73%
other investing activites
4.92M
-
20K
-
net cash used for investing activites
4.92M
-
9.36M
90.26%
-44.46M
575.22%
-39.50M
11.16%
9.03M
122.86%
8.73M
3.31%
-38.90M
545.53%
-30.18M
22.41%
-9.39M
68.90%
debt repayment
-625K
-
-625K
0%
-3.13M
400%
common stock issued
8K
-
49.91M
623,825%
122K
-
108.22M
88,608.20%
-135K
100.12%
common stock repurchased
1K
-
dividends paid
other financing activites
-140K
-
148K
-
642K
333.78%
net cash used provided by financing activities
-625K
-
-617K
1.28%
46.79M
7,683.31%
10.32M
77.93%
-321K
103.11%
122K
138.01%
108.22M
88,608.20%
13K
99.99%
642K
4,838.46%
effect of forex changes on cash
net change in cash
215K
-
3.49M
1,525.12%
43.01M
1,130.85%
-34.55M
180.33%
-2.00M
94.23%
738K
136.99%
60.97M
8,160.98%
-36.34M
159.61%
-18.95M
47.86%
cash at beginning of period
5.35M
-
5.57M
4.02%
9.06M
62.74%
52.07M
474.52%
17.52M
66.35%
15.53M
11.39%
16.26M
4.75%
77.23M
374.85%
40.89M
47.05%
cash at end of period
5.57M
-
9.06M
62.74%
52.07M
474.52%
17.52M
66.35%
15.53M
11.39%
16.26M
4.75%
77.23M
374.85%
40.89M
47.05%
21.94M
46.34%
operating cash flow
-4.08M
-
-5.24M
28.62%
40.67M
875.63%
-5.38M
113.22%
-10.70M
99.07%
-8.12M
24.19%
-8.36M
3.01%
-6.17M
26.20%
-10.20M
65.38%
capital expenditure
-52K
-
-31K
40.38%
-22K
29.03%
-309K
1,304.55%
-147K
52.43%
-119K
19.05%
-82K
31.09%
-166K
102.44%
free cash flow
-4.08M
-
-5.30M
29.90%
40.64M
867.43%
-5.40M
113.28%
-11.01M
103.98%
-8.26M
24.98%
-8.48M
2.61%
-6.25M
26.27%
-10.37M
65.86%

All numbers in USD (except ratios and percentages)